Latest Medivir News & Updates

See the latest news and media coverage for Medivir. We track all announcements, press releases, and industry mentions in real time, all in one place.

Medivir

Drug discovery and development company

medivir.com

Headquarters: Huddinge, Sweden
Founded year: 1988
Company type: Public company
Number of employees: 2–50

Last updated Today

Latest news about Medivir

In short: Medivir advanced its clinical pipeline for liver cancer and bone disease while raising significant capital through multiple directed share issues.

Company announcements

Yesterday Medivir

Medivir publishes disclosure document for share admission to Nasdaq Stockholm

The document relates to a directed share issue of 85,365,854 new shares to institutional investors.

June 17 Medivir

Medivir completes directed share issue of SEK 140 million

The heavily oversubscribed issue attracts institutional and major shareholders and funds MIV-711 trials, pediatric formulation, manufacturing, and clinical team resources.

June 17 Medivir

Medivir summons shareholders to extraordinary general meeting

Meeting is July 20, 2026, to approve a directed share issue to Hallberg Management AB in connection with a SEK 140 million capital raising.

June 9 Medivir

Medivir publishes positive fostrox-lenvatinib trial results

The phase 1b/2a study showed promising efficacy and tolerability in advanced liver cancer patients after immunotherapy.

Media coverage

June 17 Dagens Juridik

Lindahl advisor to Medivir in directed share issue of approximately SEK 140 million - Dagens Juridik

Law firm Lindahl has acted as legal advisor to Medivir AB (publ) in connection with a directed share issue of approximately SEK 140 million to Swedish and international institutional...

June 9 The Globe and Mail

Medivir’s fostrox combo shows promising liver cancer data in key journal

Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools. Designed for personal research, portfolio monitoring, and AI-assisted investment ...

May 7 FinanzNachrichten

Medivir AB: Resolutions at the Annual General Meeting in Medivir on 7 May 2026

Medivir AB (publ) held its annual general meeting today on 7 May 2026. The annual general meeting was held by physical presence of shareholders and...

May 5 Dagens industri

Medivir reduces the loss

The specialist pharmaceutical company Medivir reports an EBITDA result for the first quarter of -8.8 million kronor (-12.6).

Never miss news about Medivir

Track Medivir and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Medivir competitors & trending companies

Browse news for competitors to Medivir and other trending companies.